Mycobacterium boenickei

Revision as of 18:09, 18 September 2017 by WikiBot (talk | contribs) (Changes made per Mahshid's request)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Mycobacterium boenickei
Scientific classification
Kingdom: Bacteria
Phylum: Actinobacteria
Order: Actinomycetales
Suborder: Corynebacterineae
Family: Mycobacteriaceae
Genus: Mycobacterium
Species: M. boenickei
Binomial name
Mycobacterium boenickei
Schinsky et al. 2004, ATCC 49935

WikiDoc Resources for Mycobacterium boenickei

Articles

Most recent articles on Mycobacterium boenickei

Most cited articles on Mycobacterium boenickei

Review articles on Mycobacterium boenickei

Articles on Mycobacterium boenickei in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mycobacterium boenickei

Images of Mycobacterium boenickei

Photos of Mycobacterium boenickei

Podcasts & MP3s on Mycobacterium boenickei

Videos on Mycobacterium boenickei

Evidence Based Medicine

Cochrane Collaboration on Mycobacterium boenickei

Bandolier on Mycobacterium boenickei

TRIP on Mycobacterium boenickei

Clinical Trials

Ongoing Trials on Mycobacterium boenickei at Clinical Trials.gov

Trial results on Mycobacterium boenickei

Clinical Trials on Mycobacterium boenickei at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mycobacterium boenickei

NICE Guidance on Mycobacterium boenickei

NHS PRODIGY Guidance

FDA on Mycobacterium boenickei

CDC on Mycobacterium boenickei

Books

Books on Mycobacterium boenickei

News

Mycobacterium boenickei in the news

Be alerted to news on Mycobacterium boenickei

News trends on Mycobacterium boenickei

Commentary

Blogs on Mycobacterium boenickei

Definitions

Definitions of Mycobacterium boenickei

Patient Resources / Community

Patient resources on Mycobacterium boenickei

Discussion groups on Mycobacterium boenickei

Patient Handouts on Mycobacterium boenickei

Directions to Hospitals Treating Mycobacterium boenickei

Risk calculators and risk factors for Mycobacterium boenickei

Healthcare Provider Resources

Symptoms of Mycobacterium boenickei

Causes & Risk Factors for Mycobacterium boenickei

Diagnostic studies for Mycobacterium boenickei

Treatment of Mycobacterium boenickei

Continuing Medical Education (CME)

CME Programs on Mycobacterium boenickei

International

Mycobacterium boenickei en Espanol

Mycobacterium boenickei en Francais

Business

Mycobacterium boenickei in the Marketplace

Patents on Mycobacterium boenickei

Experimental / Informatics

List of terms related to Mycobacterium boenickei

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Mycobacterium boenickei

Mycobacterium boenickei is a member of the Mycobacterium fortuitum third biovariant complex. They are rapidly growing ubiquitous environmental organisms that normally inhabit soil, dust and water. These organisms frequently are human pathogens that cause a wide spectrum of clinically significant disease. It is important for practitioners to be aware of these organisms as possible etiological agents, as they are resistant to most first-line anti-tuberculous agents.

  • Etymology: boenickei, of Bönicke, in honour of the contribution of Rudolf Bönicke, a German mycobacteriologist, who first recognized the heterogeneity within the Mycobacterium fortuitum complex.

Description

Microscopy

  • The organisms are acid-fast, Gram-positive, pleomorphic bacilli. Long filamentous forms are often observed, but spores and capsules are absent.

Colony characteristics

  • Colonies are matt, domed, scalloped-edged and do not demonstrate aerial hyphae.
  • On heart infusion agar with 5 % (v/v) rabbit blood for 2 days at 35 °C. shows white to slightly beige, small-diameter (approx. 1 mm) colonies.

Physiology

  • Growth occurs on Löwenstein–Jensen medium at 35 °C in less than 7 days, but no growth occurs at 42 °C
  • Growth occurs on 5 % NaCl and on MacConkey's agar without crystal violet at 28 °C
  • None of the isolates grow in lysozyme or utilize citrate, and five of six (83 %) isolates produce arylsulfatase in 3 days.
  • The semi-quantitative catalase activity of all isolates is reactive (>45 mm).

Differential characteristics

  • The nearest phylogenetic neighbours, according to 16S rRNA gene sequence similarity, are M. neworleansense and all M. porcinum isolates studied (all 99·9 %).

Pathogenesis

  • Reported infections include skin and soft-tissue abscesses with associated osteomyelitis, bacteraemia, endocarditis, keratitis, lymphadenitis, peritonitis, post-surgical infections, pulmonary infections and disseminated disease. Involvement of the central nervous system is rare, but meningitis may develop after trauma or surgery. The immunocompromised patient is at special risk for developing severe diseases, especially catheter-related infection with bacteraemia.

Type Strain

  • Type strain: strain W5998 = ATCC 49935 = DSM 44677.
  • The type strain, was first isolated from a leg wound

References

Schinsky, M. F., et Al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates. Int. J. Syst. Evol. Microbiol., 2004, 54, 1653-1667.
de:Mycobacterium boenickei nl:Mycobacterium boenickei Template:SIB


Template:WikiDoc Sources